Lv11
30 积分 2024-01-25 加入
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
44分钟前
待确认
Fifty years of monoclonals: the past, present and future of antibody therapeutics
1小时前
已完结
A non-classical view of antibody properties: Allosteric effect between variable and constant regions
1个月前
已完结
Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines
1个月前
已完结
Novel recombinases for large DNA insertions
6个月前
已完结
IgE and non-IgE-mediated pathways in anaphylaxis
11个月前
已完结
Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects
1年前
已完结
皖公网安备34019202002308
